Old Web
English
Sign In
Acemap
>
authorDetail
>
Anne M. Pilaro
Anne M. Pilaro
Center for Drug Evaluation and Research
Medicine
Internal medicine
Cancer research
Oncology
Clinical endpoint
6
Papers
294
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
First FDA Approval of Dual Anti-HER2 Regimen: Pertuzumab in Combination with Trastuzumab and Docetaxel for HER2-Positive Metastatic Breast Cancer
2013
Clinical Cancer Research
Gideon M. Blumenthal
Nancy S. Scher
P. Cortazar
Somesh Chattopadhyay
Shenghui Tang
Pengfei Song
Qi Liu
Kimberly Ringgold
Anne M. Pilaro
Amy Tilley
Kathryn E. King
Laurie Graham
Barbara L. Rellahan
Wendy C. Weinberg
Bo Chi
Colleen Thomas
Patricia Hughes
Amna Ibrahim
Robert Justice
Richard Pazdur
Show All
Source
Cite
Save
Citations (78)
Eribulin Mesylate for the Treatment of Patients with Refractory Metastatic Breast Cancer: Use of a “Physician's Choice” Control Arm in a Randomized Approval Trial
2012
Clinical Cancer Research
Martha Donoghue
Steven J. Lemery
Weishi Yuan
Kun He
Rajeshwari Sridhara
Stacy Shord
Hong Zhao
Anshu Marathe
Lori Kotch
Josephine M. Jee
Ying Wang
Liang Zhou
William M. Adams
Vaishali Jarral
Anne M. Pilaro
Richard T. Lostritto
Joseph E. Gootenberg
Patricia Keegan
Richard Pazdur
Show All
Source
Cite
Save
Citations (34)
U.S. Food and Drug Administration Approval: Ofatumumab for the Treatment of Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine and Alemtuzumab
2010
Clinical Cancer Research
Steven J. Lemery
Jenny Zhang Zhang
Mark D. Rothmann
Jun Yang
Justin C. Earp
Hong Zhao
Andrew McDougal
Anne M. Pilaro
Raymond Chiang
Joseph E. Gootenberg
Patricia Keegan
Richard Pazdur
Show All
Source
Cite
Save
Citations (81)
Testing of Adenoviral Vector Gene Transfer Products
2002
Steven R. Bauer
Anne M. Pilaro
Karen D. Weiss
Show All
Source
Cite
Save
Citations (1)
1